Bipyridyl-substituted benzo[1,2,3]triazoles as a thermally stable electron transporting material for organic light-emitting devices

We developed new electron-transporting materials (ETMs) for organic light-emitting devices (OLEDs) based on benzo[1,2,3] triazole and two bipyridines. Four derivatives based on the same skeleton were synthesized with four different substituents: phenyl (BpyBTAZ-Ph), biphenyl (-BP), m-terphenyl (-mTP), and o-terphenyl (-oTP). These BpyBTAZ compounds have good thermal stabilities, and their decomposition temperatures were greater than 410 degrees C, which is significantly higher than that of tris(8-quinolinolato) aluminium (Alq), the conventional OLED material. BpyBTAZ compounds show preferable amorphous nature, and moreover, the glass transition temperatures (T(g)s) of both BpyBTAZ-TP compounds exceed 100 degrees C. Furthermore, BpyBTAZ-BP exhibits no melting point and is fully amorphous. The electron affinities of the materials are as large as 3.3 eV and their electron mobility is sufficiently high. These characteristics accounted for a reduction in the operational voltage of OLEDs with BpyBTAZ compounds compared with the reference device with Alq as an ETM. Specifically, the electron mobility of all the BpyBTAZ compounds exceeds 1 x 10(-4) cm(2) V(-1) s(-1) at an electric field of 1 MV cm(-1). In addition, it was revealed that both BpyBTAZ-TP-based devices showed longer luminous lifetimes and smaller voltage increases during continuous operation at 50 mA cm(-2), compared with the Alq reference device.ArticleJOURNAL OF MATERIALS CHEMISTRY. 21(32):11791-11799 (2011)journal articl

Bipyridyl-substituted benzo[1,2,3]triazoles as a thermally stable electron transporting material for organic light-emitting devices

We developed new electron-transporting materials (ETMs) for organic light-emitting devices (OLEDs) based on benzo[1,2,3] triazole and two bipyridines. Four derivatives based on the same skeleton were synthesized with four different substituents: phenyl (BpyBTAZ-Ph), biphenyl (-BP), m-terphenyl (-mTP), and o-terphenyl (-oTP). These BpyBTAZ compounds have good thermal stabilities, and their decomposition temperatures were greater than 410 degrees C, which is significantly higher than that of tris(8-quinolinolato) aluminium (Alq), the conventional OLED material. BpyBTAZ compounds show preferable amorphous nature, and moreover, the glass transition temperatures (T(g)s) of both BpyBTAZ-TP compounds exceed 100 degrees C. Furthermore, BpyBTAZ-BP exhibits no melting point and is fully amorphous. The electron affinities of the materials are as large as 3.3 eV and their electron mobility is sufficiently high. These characteristics accounted for a reduction in the operational voltage of OLEDs with BpyBTAZ compounds compared with the reference device with Alq as an ETM. Specifically, the electron mobility of all the BpyBTAZ compounds exceeds 1 x 10(-4) cm(2) V(-1) s(-1) at an electric field of 1 MV cm(-1). In addition, it was revealed that both BpyBTAZ-TP-based devices showed longer luminous lifetimes and smaller voltage increases during continuous operation at 50 mA cm(-2), compared with the Alq reference device.ArticleJOURNAL OF MATERIALS CHEMISTRY. 21(32):11791-11799 (2011)journal articl

Efficacy and safety of short-term therapy with indigo naturalis for ulcerative colitis: An investigator-initiated multicenter double-blind clinical trial.

IntroductionIndigo naturalis (IN) is a blue pigment extracted from Assam indigo and other plants and has been confirmed to be highly effective for ulcerative colitis (UC) treatment in several clinical studies.ObjectiveWe conducted a multicenter double-blind study to confirm the efficacy and safety of short-term IN administration.MethodsA multicenter, randomized controlled trial was conducted between December 2015 and October 2018 in our facilities. Forty-six patients with mild to moderate active UC (Lichtiger index: 5-10) were randomly assigned to the IN group or the placebo group and received 5 capsules (500 mg) twice a day for 2 weeks. We investigated the efficacy according to blood tests and the Lichtiger index before and after administration, and we also examined adverse events.ResultsThe analysis included 42 patients (20 males, 22 females) with an average age of 45 years. Nineteen patients were assigned to the placebo group, and 23 were assigned to the IN group. After treatment administration, in the placebo group, no change in the Lichtiger index was observed (7.47 to 6.95, p = 0.359), and hemoglobin was significantly reduced (12.7 to 12.4, p = 0.031), while in the IN group, the Lichtiger index (9.04 to 4.48, p = 0.001) and albumin (4.0 to 4.12, p = 0.022) improved significantly. Mild headaches were observed in 5 patients and 1 patient in the IN and placebo groups, respectively.ConclusionsShort-term administration of IN is highly effective without serious adverse events such as pulmonary hypertension or intussusception and may prevent the occurrence of serious adverse events